跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Feiba - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Feiba
Approved
STANDARD
Feiba
Baxter AG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b7124f8b34b8000e
Company
Baxter AG
Type
Standard
Approval Details
Approval Id
b7124f8b34b8000e
Drug Approval Philippines Name
Feiba
Product Name
Feiba
Registration Number
BR-1445
Brand Name
Feiba
Generic Name
Powder for Solution for Infusion (IV)
Dosage Form
Powder for Solution for Infusion (IV)
Dosage Strength
2500 U/50 mL (50 U/mL)
Manufacturer
Baxter AG
Importer
Takeda Healthcare Philippines Inc.
Distributor
Takeda Healthcare Philippines Inc.
Company Detail Path
/organization/baxter-ag
Issuance Date
19 June 2023
Expiry Date
19 June 2028
Pharmacologic Category
Blood Coagulation Factors
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b7124f8b34b8000e
Type
Standard
Back to Philippines FDA Approvals